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Abstract  
Many plant substances are known for their interference with the central nervous system (CNS). Dioclea grandiflora Mart. Ex. Benth (Fabaceae) is a plant 
used in folk medicine to treat prostate disorders and kidney stones whose extracts from its seeds and root barks were reported to have a significant activity on 
the CNS and analgesic effect in rodents. In this study, the psychopharmacological activities of D. grandiflora were investigated, using the pods of this plant. 
Swiss mice were submitted to acute treatments with ethanol extract from the pods of D. grandiflora (EDgP) at doses of 75, 150 and 300 mg/kg by 
intraperitoneal administration followed by the evaluation of anxiety, depressant and anticonvulsant-related responses. The treatment with EDgP produced a 
depressant activity on the CNS and a sedative effect in mice. These findings suggest that EDgP has a central activity in mice, indicating an anxiogenic effect. 
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Resumen 
Varias sustancias de plantas son conocidas por su acción en el sistema nervioso central (SNC). La Dioclea grandiflora Mart. Ex. Benth (Fabaceae) es una 
planta utilizada en la medicina popular para tratar enfermedades en la próstata y piedras en los riñones, cuyos extractos de sus semillas y de las cáscaras de 
sus raíces presentan una actividad significativa sobre el SNC y efecto analgésico en roedores. En este estudio, las actividades psicofarmacológicas de D. 
grandiflora fueron investigadas, utilizando la vaina de la planta. Camudongos Swiss fueron sometidos a tratamientos agudos por la administración 
intraperitoneal del extracto etanólico de la vaina de D. grandiflora (EDgP) en dosis de 75, 150 y 300 mg/kg administrados intraperitonealmente seguida por la 
evaluación de respuestas relacionadas con la ansiedad, depresión y anticonvulsivo. El tratamiento con EDgP produjo una actividad depresora sobre el sistema 
nervioso central y un efecto sedante en camundongos. Estos resultados sugieren que EDgP tiene una actividad central en camundongos, indicando un efecto 
ansiogénico. 
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INTRODUCTION 
The clinical use of a large number of medicines such 
as those employed in the treatment of the central 
nervous system (CNS) disorders is generally limited 
by the occurrence of undesirable side effects. 
Therefore, the search and development of new 
medications possessing effective therapeutical 
properties without adverse effects on the organism 
would be of great interest in the scientific community 
worldwide. Medicinal plants are a well-recognized 
source of substances with potential to provide 
alternative remedies for our ailments. However, a 
proper evaluation of their actual efficacy in the 
treatment of diseases or the occurrence of unwanted 
effects must be addressed. For instance, accumulating 
pharmacological data indicate that certain substances 
present in plants are capable of interfering with the 
normal functioning of the CNS, producing 
psychomotor impairment or depressant activity 
(Emamghoreishi et al., 2005; Habib et al., 2012). 
Dioclea grandiflora Mart. Ex. Benth 
(Fabaceae), popularly known as “mucunã”, “mucunã-
de-caroço” and “olho-de-boi” or bullseye, is a vine 
that grows in the “caatinga” and “cerrado” regions of 
Northeastern Brazil. According to popular tradition, 
the seed and root bark of this plant have been widely 
used to treat prostate disorders and kidney stones 
(Lima, 1989). Phytochemical studies showed the 
presence of various substances in D. grandiflora, such 
as the flavanones paraibanol, agrandol, and diosalol 
(Jenkins et al., 1999), dioclein (Bhattacharyya et al., 
1995) and dioflorin (Bhattacharyya et al., 1998), and 
the dihydroflavonol, dioclenol (Bhattacharyya et al., 
1997), isolated from the chloroformic (CHCl3) soluble 
portion of the ethanol root bark extract of this plant. 
Previous investigations evidenced a significant CNS 
activity of the CHCl3 and the ethanol extracts obtained 
from the dried root bark (Batista et al., 1995), and the 
hydroalcoholic extract from the seeds of D. 
grandiflora (Almeida et al., 2003). Its major 
constituent, dioclein, was reported to have significant 
analgesic effect in rodents (Batista et al., 1995) and a 
potent vasorelaxant endothelium dependent effect in 
the rat aorta (Lemos et al., 1999). A pharmacological 
screening also revealed the antinociceptive activity of 
dioclenol and dioflorin in mice (Almeida et al., 2000).  
In addition to the seeds and root bark of D. 
grandiflora, a study was carried out using another part 
of this plant, namely the pods, and reported an 
effective antinociceptive activity in mice (Sá et al., 
2010). Therefore, the aim of this study was to further 
investigate the psychopharmacological activities of D. 
grandiflora pods, in a short-term treatment protocol in 
mice. 
 
MATERIAL AND METHODS 
Plant material and preparation of extract 
Aerial parts of D. grandiflora were collected in Santa 
Rita, Paraíba, Brazil and authenticated by Dr. Fatima 
Agra by means of morphological analysis of stem, 
leaves, seeds and pods. A voucher specimen registered 
under the number 4440-JPB, MO is deposited in the 
Lauro Pires Xavier (JPB) Herbarium of the Federal 
University of Paraíba (UFPB). The pods was dried in 
an oven at 40°C, and subsequently powdered (135.14 
g) and extracted with 70% ethanol/water (v/v%) for 72 
h in a Soxhlet apparatus. The extract was then 
concentrated using a rotary evaporator and a dry solid 
was obtained, corresponding to a yield of 4.70%.  
 
Animals 
Male Swiss mice (Mus musculus) weighing about 30 g 
were obtained from the vivarium of the Laboratory of 
Pharmaceutical Technology of UFPB, where they 
were born and bred. The animals were housed under 
standard laboratory conditions, with a 12- h light/12- h 
dark photoperiod, with the light period beginning at 
06:00 h. They were fed on rat chow pellets and 
received water ad libitum. The room temperature was 
kept at 23 ± 1°C and all experiments were conducted 
between 10:00 and 16:00 h. The experimental protocol 
was approved by the Ethics Committee of the 
Laboratory of Pharmaceutical Technology of UFPB 
(protocol number 0404/08). For each test, the animals 
were selected at random and divided evenly into five 
groups of 10 animals to be used as follows. All 
animals were brought to the test room at least 1 h prior 
to the experiments and were not tested more than once. 
The number of animals used, as well as the intensity of 
noxious procedures, was kept to a minimum 
considered necessary to demonstrate the effects of the 
treatments. 
 
Pentobarbital-induced sleep time 
The animals were injected i.p. with sodium 
pentobarbital (40 mg/kg) after 30 min of i.p. 
administration of EDgP at the dose level of 300 mg/kg 
of body weight or distilled water (10 ml/kg), used as 
the control group. After administration of sodium 
pentobarbital, the latency (in seconds), which is the 
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interval between the pentobarbital administration and 
the beginning of the sleeping time, and the time (in 
seconds) between loss and recovery of the righting 
reflex were recorded (Speroni and Minghetti, 1988; 
Franco et al., 2005). 
 
Elevated plus-maze test 
The elevated plus-maze apparatus consisted of four 
arms (30 cm) elevated 39 cm above the floor. Each 
arm was positioned at 90º relative to the adjacent arms 
and all arms were connected through a central area (5 
x 5 cm), forming a plus sign. The animals were 
injected i.p. with diazepam (1 mg/kg), used as positive 
control, or EDgP at the dose levels of 75, 150 and 300 
mg/kg of body weight while animals injected i.p. with 
the same volume of distilled water (10 ml/kg) were 
used as the control group. Thirty minutes after 
treatment, each mouse was placed at the center of the 
maze facing one of the open arms. The number of 
entries into and time spent (in seconds) on the open 
and closed arms were recorded for 5 min. Entry into 
an arm was defined as the animal having crossed with 
all four paws the dividing line between the central area 
and the arm (Herrera-Ruiz et al., 2008; Han et al., 
2009; Grundmann et al., 2009). After each trial, the 
plus-maze was carefully cleaned with 10% ethanol 
solution. 
 
Hole-board test 
The hole-board apparatus (UGO Basile, Italy) 
consisted of a gray panel (40 x 40 cm; 2.2 cm thick) 
containing 16 equidistant holes of 3 cm in diameter. 
The animals were injected i.p. with diazepam (1 
mg/kg), used as positive control, or EDgP at the dose 
levels of 75, 150 and 300 mg/kg of body weight, or 
distilled water (10 ml/kg), used as the control group. 
Thirty minutes after treatment, each mouse was placed 
at the center of the hole-board facing away from the 
observer and the number of head dips was counted for 
5 min by photocells placed below the surface of the 
hole (Han et al., 2009). In addition, ambulation and 
time spent on the board without moving (immobility 
time) were also measured. After each trial, the hole-
board was carefully cleaned with 10% ethanol 
solution. 
 
Open field test 
The open field apparatus consisted of a white painted 
area measuring 55 cm in diameter with a 100 W lamp 
attached and used as the main source of illumination. 
The floor of the open field was divided into several 
units by black painted lines. The animals were injected 
i.p. with diazepam (1 mg/kg), used as positive control, 
or EDgP at the dose levels of 75, 150 and 300 mg/kg 
of body weight, or distilled water (10 ml/kg), used as 
the control group. Thirty minutes after treatment, each 
mouse was placed at the center of the apparatus and 
ambulation, rearing and grooming were measured for 
5 min (Cícero et al., 2000; Franco et al., 2005). After 
each trial, the open field was carefully cleaned with 
10% ethanol solution. 
 
Pentylenetetrazole test 
Pentylenetetrazole (PTZ) was used to induce clonic-
tonic convulsion. The animals were injected i.p. with 
60 mg/kg of PTZ after 30 min of i.p. administration of 
diazepam (4 mg/kg), used as positive control, or EDgP 
at the dose levels of 75, 150 and 300 mg/kg of body 
weight, or distilled water (10 ml/kg), used as the 
control group. After PTZ administration, mice were 
individually placed in boxes and observed for 15 min 
to detect the occurrence of convulsion. Tonic PTZ 
convulsion was characterized as a tonic ventroflexion 
followed by a full extension of forelimb and hind limb. 
The latency (in seconds), which is the time elapsed 
until the occurrence of the first episode of clonic PTZ 
convulsion, was recorded (N`gouemo et al., 1996). 
The animals were kept under observation for a period 
of 24 h after PTZ administration and the incidence of 
mortality was noted.  
 
Electroshock test 
Electroconvulsive shock (5 mA) was delivered 
through an electrode attached to the right ear lobe of 
mice to induce tonic hind limb extension. The animals 
were injected i.p. with phenytoin (25 mg/kg), used as 
positive control, or EDgP at the dose levels of 75, 150 
and 300 mg/kg of body weight, or distilled water (10 
ml/kg), used as the control group. Thirty minutes after 
treatment, each mouse received the electroshock and 
the occurrence and duration (in seconds) of tonic 
convulsion were noted (N`gouemo et al., 1996). An 
animal was considered protected if no convulsion 
occurred. 
 
Statistical analysis 
The data were expressed by mean ± standard error 
mean (S.E.M.) and were analyzed for statistical 
significance using one-way analysis of variance 
(ANOVA) followed by Bonferroni`s multiple 
comparison test or Student`s t-test depending on the 
case. The tests were performed using GraphPad Prism 
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version 4.00 for Windows, GraphPad Software, San 
Diego California USA, www.graphpad.com. The 
difference between groups were considered significant 
when P < 0.05.  
 
RESULTS 
Pentobarbital-induced sleep time 
The induction of sleep with pentobarbital is a classic 
pharmacological model for the screening of sedative-
hypnotic drugs. As shown in Table 1, the treatment 
with EDgP at a dose level of 300 mg/kg significantly 
reduced the latency but did not produce potentiation of 
pentobarbital sleeping time in the treated animals in 
comparison with the results obtained in the control 
group. 
 
Table 1 
Effect of pentobarbital-induced sleep time in mice. 
 
Treatment Latency (s) Sleep time (s) 
Control
a
            345.1 ± 43.7 4633 ± 676.5 
EDgP (300 mg/kg) 221.7 ± 25.4* 4980 ± 564.9 
Values are mean ± S.E.M. (n = 10). * P < 0.05 vs control.  
a = 10 ml/kg of distilled water. s = seconds 
 
Elevated plus-maze test  
One-way analysis of variance showed a significant 
increase in the amount of time spent on the open arms 
after the administration of positive control diazepam 
(1 mg/kg) when compared to control. The animals 
treated with EDgP at 75, 150 and 300 mg/kg also 
spent more time on the open arms, but the values 
obtained were not statistically significant. However, a 
significant decrease in the number of entries into the 
closed arms was observed at all dose levels (Table 2). 
No significant variations were observed between the 
groups. 
 
Table 2 
Effect of EDgP on the elevated plus-maze in mice. 
 
Treatment Dose 
(mg/kg) 
Time spent in the arms (s) Number of entries 
 Open Closed Open Closed 
Control
a
  49.8 ± 9.4 164.2 ± 10.0 4.6 ± 0.7 10.1 ± 0.8 
EDgP 75 88.1 ± 21.7 141.1 ± 22.3 4.0 ± 0.9 5.4 ± 0.4** 
 150 63.0 ± 23.3 178.1 ± 25.5 3.5 ± 0.9 4.5 ± 0.7** 
 300 95.8 ± 25.0 145.5 ± 25.2 3.5 ± 0.9 3.9 ± 0.7** 
Diazepam 1 130.6 ± 16.7* 124.2 ± 17.8 7.0 ± 1.0  8.4 ± 1.4 
Values are mean ± S.E.M. (n = 10). * P < 0.05 vs control;  
** P < 0.001 vs control, Bonferroni test. a = 10 ml/kg of distilled water. s = seconds. 
 
 
 
Hole-board test 
The sedative effect of EDgP was confirmed in the 
hole-board test as the extract at doses of 75, 150 and 
300 mg/kg, as well as diazepam (1 mg/kg i.p.), 
significantly decreased the number of head dips 
(Figure 1) and significantly increased the immobility 
time relative to the control group (Figure 2). EDgP 
also reduced ambulation, but only the higher dose (300 
mg/kg) produced a significant decrease in this 
parameter (Table 3). The doses were not significantly 
different between them. 
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Open field test 
EDgP at doses of 75, 150 and 300 mg/kg and 
diazepam (1 mg/kg i.p.) significantly reduced the 
spontaneous motor activities (ambulation) (Figure 3) 
and rearing (Figure 4) in mice in the open field. At 
doses of 75 and 150, EDgP reduced the grooming 
activity of the animals, whereas the higher dose of 
EDgP and diazepam did not decrease this activity at a 
significant level (Figure 5). No significant difference 
was observed between the doses in any of the 
parameters analyzed in this test. 
 
 
Figure 1 
Effect of EDgP on head dips in the hole-board test in mice.  
Values are mean ± S.E.M. (n = 10). *P < 0.001 vs control. DZP – Diazepam. 
 
 
Figure 2 
Effect of EDgP on immobility time in the hole-board test in mice.  
Values are mean ± S.E.M. (n = 10). *P < 0.001 vs control. DZP – Diazepam. 
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Table 3 
Effect of EDgP on ambulation in the hole-board test in mice 
Treatment Dose (mg/kg, i.p.) Latency (s) 
Control
a
  16.7 ± 1.9 
EDgP 75 10.1 ± 2.2 
 150  8.1 ± 2.5 
 300   6.8 ± 2.1* 
Diazepam 1        14.9 ± 2.8 
Values are mean ± S.E.M. (n = 10). * P < 0.05 vs control.  
a = 10 ml/kg of distilled water. s = seconds. 
 
 
 
 
 
 
Figure 3 
Effect of EDgP on spontaneous locomotion in the open field test in mice.  
Values are mean ± S.E.M. (n = 10). *P < 0.05, **P < 0.01, ***P < 0.001 vs control. DZP – Diazepam. 
 
Pentylenetetrazole test 
PTZ (60 mg/kg) induction of clonic convulsion in 
control and EDgP-treated (75, 150 and 300 mg/kg) 
animals revealed that EDgP neither blocked nor 
significantly delayed the onset of clonic convulsion 
(Table 4). Tonic PTZ convulsion occurred in 22% of 
mice and mortality was low (one death in the 150 
mg/kg-treated and three deaths in the 300 mg/kg-
treated group). 
 
Electroshock test 
In the control and EDgP-treated groups, all the 
animals exhibited tonic hind limb extension after 
electroshocks. However, pretreatment with tonic 
EDgP did not prevent the occurrence of tonic 
convulsion, but surprisingly increased the duration of 
the seizure activity. As expected, the phenytoin-treated 
animals (25 mg/kg) did not exhibit any tonic 
convulsions (Figure 6). 
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Figure 4 
Effect of EDgP on rearing in the open field test in mice.  
Values are mean ± S.E.M. (n = 10). *P < 0.05, **P < 0.001 vs control. DZP – Diazepam. 
 
 
Figure 5 
Effect of EDgP on grooming in the open field test in mice.  
Values are mean ± S.E.M. (n = 10). *P < 0.01, **P < 0.05 vs control. DZP – Diazepam. 
 
DISCUSSION 
D. grandiflora seeds and root bark extracts 
were shown to produce significant activity on the CNS 
(Batista et al., 1995). They are reported to have 
flavanones such as dioclein (Figure 7a), dioclenol 
(Figure 7b) and dioflorin (Figure 7c), which have been 
shown to have antinociceptive activity in rodents 
(Bhattacharyya et al., 1995; Bhattacharyya et al., 
1997; Bhattacharyya et al., 1998). In this study, an 
extract obtained from the pods of D. grandiflora was 
used in mice models to further assess its 
psychopharmacological activities. The doses 
employed were based on acute toxicity studies and 
corresponded to 1/10 (75 mg/kg), 1/5 (150 mg/kg) and 
1/2.5 (300 mg/kg) of the extract LD50 (753 mg/kg 
i.p). These doses were lower than the doses used 
previously in studies with D. grandiflora seeds and 
root bark (Almeida et al., 2000). The results obtained 
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demonstrate that the systemic administration of EDgP 
to mice displayed a depressant activity on the CNS but 
not a clear anti-anxiety response, according to the 
elevated plus-maze, hole-board, open field and 
pentobarbital-induced sleep tests. 
Table 4 
Effect of pentylenetetrazole in mice. 
 
Treatment Dose (mg/kg, i.p.) Latency (s) 
Control
a
  208.4 ± 78.2 
EDgP 75 157.6 ± 20.0 
 150   388.6 ± 106.4 
 300 169.1 ± 29.5 
Diazepam 4 900.0 ±   0* 
Values are mean ± S.E.M. (n = 10). * P < 0.05 vs control.  
a = 10 ml/kg of distilled water. s = seconds. 
 
 
Figure 6 
Effect of EDgP on duration of tonic convulsion in the electroshock test in mice. 
 Values are mean ± S.E.M. (n = 10). *P < 0.01, **P < 0.05 vs control. 
 
It is known that some flavonoids possess 
anxyolitic, sedative, pro-convulsant, and anti-
convulsant effect on the CNS (Fernandez et al., 2004; 
Estrada-Reys et al., 2010). In addition, many 
flavonoids and their derivatives have been shown to 
bind to the benzodiazepine site of the GABAA receptor 
with resulting depressant actions in mice (Marder and 
Paladini, 2002; Fernandez et al., 2006; Aguirre-
Hernandez et al., 2007; Wang et al., 2010). D. 
grandiflora is a plant rich in flavonoids, therefore it is 
possible that the presence of these substances could 
account for its effects on the CNS. For instance, D. 
grandiflora was shown to exert ansiolitic-like effects 
on mice after the administration of alcoholic fraction 
obtained from the stem bark of this species by use of 
various behavioral laboratory-based research models, 
including marble-burying, hole-board and elevated 
plus maze tests. The effect of the flavonoid dioclenol 
was also evidenced in the elevated plus maze by 
displaying significant action in the time spent in open 
arms; in the hole-boar, showing significant increase in 
the time spent in the head-dip, and by exhibiting 
increase marble-burying behavior (De Almeida et al., 
2009). 
The elevated plus-maze test is the most widely 
used model for rodent anxiety evaluation of novel 
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substances (Pellow et al., 1985; Lister, 1987), in which 
natural stimuli such as fear of unfamiliar open area 
and heights are used to induce anxiety in mice and rats 
(Grundmann et al., 2007). The parameters of anxiety 
analyzed in this test, such as frequency of entries into 
the open arms and the time spent in open arms are 
generally increased by anxiolytic substances, which 
are believed to act via the GABAA receptor complex. 
This signaling pathway justifies the use of diazepam as 
a positive control because this drug is used as a 
standard anxiolytic employed in behavioral 
pharmacology (Han et al., 2009) and is known to 
increase the frequency of open arm entries and time 
spent in the open arms (Moser, 1989; Emamghoreishi 
et al., 2005). In this study, EDgP did not exhibit an 
anxiolytic activity similar to that observed at 1 mg/kg 
of diazepam as it did not increase the time spent in the 
open arms at a significant level in any of the doses 
analyzed (75, 150 and 300 mg/kg). However, in the 
hole-board test, the ansiolitic effect of EDgP became 
more evident since EDgP significantly decreased the 
number of head dips and increased immobility time 
displayed by the animals, indicating a depressant 
activity of the seed pod extract on the CNS. The hole-
board is another method used to measure the animal`s 
response to a novel environment and to assess 
emotionality, anxiety and/or responses to stress (Nolan 
and Parkes, 1973; Han et al., 2009). In this test, head-
dipping behavior may change in response to the 
emotional state of the animal and an increase in this 
behavior could reflect the expression of an anxiolytic 
reaction of the animal (Takeda et al., 1998, Han et al., 
2009).  
 
Figure 7 
Dioclea grandiflora major constituents. (a) dioclein; (b) dioclenol; (c) dioflorin. 
 
The open field test was used to evaluate the 
exploratory and emotionality activity of animals 
(Carlini et al., 1986). EDgP decreased ambulation, 
grooming and rearing, which is indicative of a 
depressive activity on the CNS. These parameters 
were taken as responses to the levels of excitability of 
CNS (Masur et al., 1971) and the behavioral effects 
observed in this study are in agreement with those 
obtained in previous investigations of depressive drugs 
of CNS (Almeida et al., 2001; Franco et al., 2005). 
The reduction of 50 to 60% in the spontaneous activity 
caused by EDgP in mice strongly suggests the 
presence of a sedative component in the activity on the 
CNS of D. grandiflora. However, other factors such as 
motor impairment or muscle relaxation may also be 
responsible for the reduction in the ambulatory 
activity. In fact, a previous study reported a transient 
impairment of motility in mice treated with the highest 
dose (300 mg/kg) of EDgP as a significant reduction 
on motor coordination was observed in animals 
submitted to the motor performance test (rota-rod) (Sá 
et al., 2010). 
The pentobarbital-induced sleep time is a 
classic pharmacological model used for the screening 
of sedative-hypnotic drugs. Therefore, this 
experimental protocol was employed in this study as 
another tool to assess the depressant activity of EDgP. 
In a previous work, the treatment of mice with the 
alcoholic fraction of the stem bark of D. grandiflora 
and dioclenol increased the duration of the sleeping 
time induced by pentobarbital and reduced latency to 
sleep (De Almeida et al., 2009). In the present 
investigation, although the extract did not significantly 
increase the sleeping time, it reduced latency, i.e. it 
decreased the amount of time taken for the animals to 
lose their righting reflex at a significant level, 
providing further evidence for the depressant effect of 
EDgP on the CNS. 
In order to evaluate a possible anti-convulsant 
action of EDgP in mice, two convulsing tests, 
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electroshock and PTZ, were performed in this study. 
The electroshock produces tonic convulsion 
characterized by tonic hind limb extension whereas 
PTZ induces clonic-tonic convulsions (Swinyard et al., 
1989; N`gouemo et al., 1996), being a good model to 
study the effects of anticonvulsant drugs on the 
propagation of seizure activity (Goodman et al., 1953; 
N`gouemo et al., 1996). EDgP did not block the PTZ-
induced seizures nor did prevent the occurrence of 
tonic convulsions. In particular, it was observed that 
EDgP at all dose levels increased the duration of tonic 
convulsions in the electroshock test, contrasting with 
the effects of the alcoholic fraction of the stem bark of 
D. grandiflora and dioclenol that played a protective 
role against PTZ convulsion (De Almeida et al., 
2009). 
In conclusion, the investigation of some of the 
neuropharmacological activities of D. grandiflora 
pods revealed that EDgP possess a depressant activity 
and a sedative effect in mice, but did not protect the 
animals against the occurrence of convulsions. The 
main constituents of D. grandiflora and the 
mechanisms involved in these pharmacological effects 
need to be investigated in further experiments. 
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